Clinical Trials Logo

Malabsorption clinical trials

View clinical trials related to Malabsorption.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04309214 Completed - Epilepsy Clinical Trials

Market Research - Acceptability Study for New MCT Fat Products

Start date: November 26, 2018
Phase: N/A
Study type: Interventional

This is a market research, observational study to evaluate the tolerability and acceptability of MCT supplements for young children, young people and adults with intractable epilepsy, GLUT-1 or PDHD from 3 years to adulthood.

NCT ID: NCT04309149 Completed - Epilepsy Clinical Trials

Market Research - Acceptability Study for a Range of MCT Products

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

This is a market research, observational study to evaluate the tolerability and acceptability of MCT supplements for young children and young people with intractable epilepsy, GLUT-1 or PDHD from 3 years to adulthood. Patients with a confirmed diagnosis of a fatty acid oxidation disorder, which requires a specialist diet including MCT will be included in this study

NCT ID: NCT03140371 Completed - Malnutrition Clinical Trials

High Energy High Protein Peptide Feed Study

Start date: July 14, 2017
Phase: N/A
Study type: Interventional

Oral nutritional supplements and enteral tube feeds are commonly used to meet the nutritional requirements of patients with disease-related malnutrition, or who require medical nutrition support for other reasons. Some patients may not tolerate standard formulations containing whole proteins (typically due to maldigestion/malabsorption) leading to gastrointestinal symptoms (i.e. vomiting and diarrhoea). Without appropriate management, this may lead to reduced nutritional intake, increased nutritional losses and risk of malnutrition in patients who may already have elevated nutritional requirements due to their clinical conditions. Poor tolerance to standard feed formulations can be managed with extensively hydrolysed (peptide-based) enteral feeds, where the protein source is provided in smaller proteins. Patients with elevated nutritional requirements, poor tolerance, maldigestion and/or malabsorption often require a higher energy, higher protein feed to meet their nutritional requirements in a smaller volume of feed. The study feed is a high energy (1.5kcal/ml), high protein (7.5g protein/100ml) peptide-based feed, available as a 500ml enteral tube feed, and a 200ml Vanilla-flavour oral nutritional supplement. The study will investigate the gastrointestinal tolerance, compliance and acceptability of the high energy, high protein peptide-based feed in 60 adult patients requiring a peptide-based feed, in several NHS sites across England. Patients will be asked to take the study feed for 28 days. Data will be recorded using questionnaires with no invasive measures. The primary outcome is gastrointestinal tolerance with secondary outcomes of compliance, acceptability, nutrient intake and anthropometry.

NCT ID: NCT02987569 Completed - Malnutrition Clinical Trials

Teen and Young Adult Connections for Support From Multidisciplinary Professionals & Peers

Start date: July 2016
Phase: N/A
Study type: Interventional

12 month study testing mobile delivery of health information and connections to professionals and peers to improve health of teen/young adult HPN users.

NCT ID: NCT02750787 Completed - Malabsorption Clinical Trials

Use of a Peptide-based Formula in an Adult Population

Start date: August 2016
Phase: N/A
Study type: Interventional

The study is designed to observe the use of a peptide-based oral nutrition supplement in adults with chronic malabsorption or maldigestion who require supplemental nutrition as assessed by a clinician.

NCT ID: NCT02590120 Completed - Malabsorption Clinical Trials

Enteral Nutrition and Amino Acid Absorption

PEPS
Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate amino acid absorption with two different type of proteins.

NCT ID: NCT01900288 Completed - Malnutrition Clinical Trials

Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research

Start date: August 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to test Mobile Technologies in Assisting Patients & Family Caregivers in Healthy Living and complex home care by connecting to information and professionals from a distance.

NCT ID: NCT01862510 Completed - Celiac Disease Clinical Trials

Detection of Celiac Disease in Patients With Hypothyroidism

Start date: March 2012
Phase: N/A
Study type: Observational

The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state are at increased risk of having celiac disease. It also attempts to determine if there is a threshold level of levothyroxine needed to maintain a euthyroid state in patients with hypothyroidism that should prompt serologic testing for celiac disease.

NCT ID: NCT00456729 Completed - Iron Deficiency Clinical Trials

Malabsorption as a Cause of Iron Treatment Failure in Infants

Start date: May 2006
Phase: N/A
Study type: Interventional

Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.